ORIC Pharmaceuticals, Inc. (FRA:4TZ)
Germany · Delayed Price · Currency is EUR 9.20
-0.80 (-8.00%)
Last updated: Jan 28, 2026, 3:58 PM CET
ORIC Pharmaceuticals Market Cap
ORIC Pharmaceuticals has a market cap or net worth of €841.04 million as of January 30, 2026. Its market cap has increased by 12.81% in one year.
Market Cap
841.04M
Enterprise Value
605.58M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€9.20
Market Cap Chart
Since April 24, 2020, ORIC Pharmaceuticals's market cap has increased from 687.22M to 841.04M, an increase of 22.38%. That is a compound annual growth rate of 3.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 841.04M | 23.96% |
| Dec 31, 2025 | 678.50M | 23.35% |
| Dec 31, 2024 | 550.06M | 21.14% |
| Dec 29, 2023 | 454.05M | 83.27% |
| Dec 30, 2022 | 247.75M | -51.33% |
| Dec 31, 2021 | 509.04M | -49.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| tonies SE | 1.18B |
| Sedlmayr Grund und Immobilien AG | 983.95M |
| Berliner Effektengesellschaft AG | 886.48M |
| Northern Data AG | 815.94M |
| Maschinenfabrik Berthold Hermle AG | 787.50M |
| Paul Hartmann AG | 777.83M |
| EUROKAI GmbH & Co. KGaA | 701.68M |
| FRoSTA Aktiengesellschaft | 656.73M |